Cancer is one of the most horrible diseases that has ever existed, and if you have ever lost a loved one to cancer you know how deeply it hurts. Cancer has long been not just a disease but also one of the most profitable business industries in the world.
In the United States, there is an estimate 340,000 cases of cancer a year; thousands of people are fighting the terrible disease and for what? The answer is simple PROFIT; pharmaceutical corporations, hospitals, retailers, and doctors around the world make billions of dollars each year. They are profiting off of your illness and they are doing it on purpose! I am positive there is a cure out there, they just can’t give it up because they would lose money.
However, with that being said there IS hope! Around twenty-five years ago Cuban doctors and microbiologists began searching for the cure. Their goal was not to make money but to find an effective solution against the disease. This search resulted in the world’s very first vaccine against lung cancer, CimaVax, and medicines successfully find application in cancer of the prostate, colon, breast, and tumors in the brain.
The FDA approved the first clinical trial to test the vaccine in the United States at the end of 2016. Roswell Park Cancer Institute has been authorized to conduct the first U.S. study of a drug developed by Cuban researchers.
“We’re still at the very early stages of assessing the promise of this vaccine, but the evidence so far from clinical trials in Cuba and Europe has been striking,” said Dr. Kelvin Lee, Jacobs Family Chair in Immunology and co-leader of the Tumor Immunology and Immunotherapy Program at Roswell Park Cancer Institute in Buffalo, New York, the research center that is evaluating CimaVax for U.S. use.
The Vaccination takes a different approach than other methods of cancer treatment, rather than target the cancer cells directly, the vaccine acts as a form of immunotherapy. Meaning it is harnessing the body’s own immune system to fight the cancer instead.
As of now, the results have been modest, on average patients younger than 60 live on average 11 months longer than those who do not receive the vaccination.
Agustin Lage, director of the Center for Molecular Immunology, said in a statement: “This is a day we have been working toward for many years. Our partnership with Roswell Park will allow us to learn things about out vaccine faster than what we could achieve working on our own, and we believe it is the best and quickest path for helping a great number of people both in Cuba and the U.S.”
Normally I would not recommend vaccinations to anybody. However, with that being said this is one step towards finding a cure to one of the deadliest diseases in the world and that is a wonderful achievement.